Atara Biotherapeutics, Inc. Is Being Investigated For Securities Law Violations And Affected Investors Are Urged To Contact The Schall Law Firm
LOS ANGELES, CA / ACCESS Newswire / February 2, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is ...
HC Wainwright Issues Optimistic Outlook for ATRA Earnings
Equities researchers at HC Wainwright increased their Q2 2025 earnings per share (EPS) estimates for shares of Atara ...
HC Wainwright Has Optimistic Outlook of ATRA Q3 Earnings
HC Wainwright increased their Q3 2025 earnings estimates for shares of Atara Biotherapeutics in a report released on Tuesday, ...
The Schall Law Firm Invites Shareholders With Losses To Join An Investigation Into Atara Biotherapeutics, Inc. For Securities Fraud
LOS ANGELES, CA / ACCESS Newswire / February 3, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is ...
Pacbiztimes.com4d
Atara will shed 50% of its workforce after FDA rejection
Atara Biotherapeutics will be completing its third large-scale layoff in four years after the biotech company announced plans to shed 50% of its workforce by the end of June. Atara, a Thousand ...
Morningstar4d
Wolf Haldenstein Adler Freeman & Herz LLP announces that it is investigating Atara Biotherapeutics, Inc. for potential violations of securities laws
The investigation concerns whether Atara Biotherapeutics, Inc. and certain of its officers and/or directors have engaged in securities fraud. Atara announced on January 16, 2025, that it had ...
news.stocktradersdaily5d
(ATRA) Investment Analysis
Check the time stamp on this data. Updated AI-Generated Signals for Atara Biotherapeutics Inc. (ATRA) available here: ATRA.
Yahoo Finance4d
Atara Biotherapeutics, Inc. (ATRA)
After hours: 7:42:27 p.m. EST ...
Yahoo Finance6d
ATRA Interactive Stock Chart | Atara Biotherapeutics, Inc. Stock - Yahoo Finance
At close: January 29, 4:00:01 PM EST Vertex Baseline Delta ...
Nasdaq6d
Where Will Iovance Biotherapeutics Be in 5 Years?
Iovance Biotherapeutics (NASDAQ: IOVA), a small-cap biotech company, has an innovative approach to treating cancer that relies on harnessing patients' cancer-fighting capabilities. Though the ...